3rd Quarter - Report

NATIONAL PATIENT ADVOCATE FOUNDATION for NATIONAL PATIENT ADVOCATE FOUNDATION

Firm
Client
Income
—
Expenses
$56,500
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Comprehensive Cancer Care Improvement Act, Johanna's Law.

LobbyistCovered position, as disclosed
NANCY DAVENPORT-ENNIS —
GRAYSON FOWLER —
AMY WOTRING —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Medicaid spending, Medicare reimbursmetn, SCHIP, Medicaid IVIG Access Act, Medicare waiting period, Medicare buy-in, health care reform, Medicaid eligibility,

LobbyistCovered position, as disclosed
NANCY DAVENPORT-ENNIS —
GRAYSON FOWLER —
AMY WOTRING —

Contacted: Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE

Budget/Appropriations BUD

Labor HHS Appropriations: appropriations levels for NIH, NCI, CDC, and AHRQ Labor HHS Appropriations: appropriations for Patient Advocate Foundation VCUP and MS Delta Health Alliance Agriculture Appropriations: appropriations level for FDA

LobbyistCovered position, as disclosed
NANCY DAVENPORT-ENNIS —
GRAYSON FOWLER —
AMY WOTRING —

Contacted: Agency for Healthcare Research & Quality (AHRQ); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.